WeVote
Log In

Bill

Bill

H 719

An act relating to hospital collaboration and state action immunity

2025-2026 Regular Session Introduced by Dave Bosch and 14 co-sponsors

The bill enables and governs hospital collaboration in Vermont with state action immunity, balancing coordinated efforts against competition and patient protections.

Read first time and referred to the Committee on Health Care
0
WeVote Research Nonpartisan
Bill Summary · H 719

Bill overview

  • Bill: H 719
  • Session: 2025-2026
  • Jurisdiction: Vermont
  • Title: An act relating to hospital collaboration and state action immunity
  • Action to date: Read first time and referred to the Committee on Health Care (2026-01-20)
  • Primary sponsors: A broad slate of co-sponsors including Dave Bosch, Mary Morrissey, Mary Howard, Chris Pritchard, Zak Harvey, Chris Keyser, Pattie McCoy, Alicia Malay, Jim Casey, Sandy Pinsonault, Larry Labor, Bill Canfield, Eric Maguire, Mike Morgan, and Christopher Howland

Purpose and intent

  • Establishes or clarifies mechanisms for hospital collaboration in Vermont.
  • Addresses immunity for state actions, potentially shielding certain hospital coordination or regulatory activities from antitrust or liability challenges.
  • Aims to balance hospital collaboration and competition with patient access and quality of care considerations.
  • Seeks to create a framework that enables hospitals to work together on shared initiatives while preserving appropriate governance and oversight.

Key provisions and changes (as indicated by the title and action)

  • Hospital collaboration: Provisions likely authorize or encourage collaboration among hospitals, which may include joint planning, resource sharing, coordinated patient care initiatives, mergers or affiliations, data sharing, or joint purchasing. The exact scope may cover clinical, administrative, or strategic activities intended to improve efficiency, access, or outcomes.
  • State action immunity: The bill references state action immunity, indicating that certain cooperative activities among hospitals could be shielded from antitrust enforcement or other regulatory liability, provided they meet specific conditions. This typically requires that actions be plausibly authorized or approved by state government and aimed at legitimate public objectives.
  • Oversight and governance: The proposal probably includes requirements for governance, disclosure, and oversight to ensure that collaborations do not harm consumers or stifle competition beyond what is necessary for public objectives.
  • Compliance framework: May establish reporting obligations, compliance plans, or criteria to determine when immunity applies, including sunset provisions, periodic reviews, or conditions for maintaining immunity status.
  • Patient and public interest safeguards: Likely incorporates protections to ensure patient access, continuity of care, pricing transparency, and quality standards in any collaborative arrangements.

Who and what is affected

  • Hospitals and health systems in Vermont that participate in or pursue collaborative arrangements.
  • Health care providers, administrators, and executives involved in hospital governance and operations.
  • Consumers/patients who rely on hospital services, with potential impacts on access, pricing, and quality of care.
  • Regulators and state agencies responsible for health care oversight, antitrust enforcement, and public health objectives.

Procedural and timeline aspects

  • Current action: Read first time and referred to the Committee on Health Care (January 20, 2026).
  • Next steps (typical for this stage): Committee may hold hearings, solicit expert testimony, and draft amendments; potential revisions before a floor vote.
  • If advanced, the bill would progress through additional readings, potential amendments, and votes in the Vermont Legislature, with potential impact pending if enacted and signed into law.
  • Effective date: Not specified in the summary; bills typically include an effective date or phased timeline upon enactment.

Potential impacts and considerations

  • Benefits: Could foster needed collaboration among hospitals to improve care coordination, reduce duplicative services, expand access, and enhance efficiency, while preserving patient protections.
  • Risks: Careful guardrails are important to prevent anticompetitive coordination, price suppression, or reduced competition. Clear criteria for immunity and ongoing oversight would be essential to avoid adverse effects on innovation and consumer choice.
  • Implementation: Success depends on precise statutory language defining what constitutes permissible collaboration, the conditions for state action immunity, reporting requirements, and enforcement mechanisms.

If you’d like, I can tailor this summary further once we have access to the bill’s full text, including specific definitions, immunity criteria, reporting requirements, and any proposed fiscal impact or regulatory changes.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.